Background: Methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa are the main causes of refractory infections that are often resistant to antimicrobial agents. In these cases, combination of agents with antimicrobial activity is being examined. However, few studies have investigated combined effects with antimicrobial agents including carbapenem and aminoglycosides.
Methods: We evaluated the effects of panipenem (PAPM) combined with 3 aminoglycosides, arbekacin, amikacin, and netilmicin, and vancomicin (VCM) with an agar dilution checkerboard technique and the fractional inhibitory concentration index against 47 strains of MRSA and 56 strains of P. aeruginosa.
Results: PAPM combined with VCM achieved a synergic effect against MRSA in 80.9%. PAPM combined with aminoglycosides showed only additive effects against MRSA and P. aeruginosa. When comparing the activity of Mueller-Hinton agar (MHA) medium with MHA medium diluted 40-fold (1/40 MHA) against P. aeruginosa, the mean minimum inhibitory concentration of PAPM was decreased to 1/16.
Conclusions: Combination of PAPM and VCM is effective against MRSA. Combinations of PAPM and aminoglycosides showed additive effects against MRSA and P. aeruginosa.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000088969 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Expression and Diagnostic Value of miR-3591-5p in Patients with Congenital Heart Disease-Associated Pulmonary Arterial Hypertension.
Lung
December 2024
Department of Cardiology, Affiliated Hospital of Nantong University, No. 20 Xisi Road, Nantong, 226000, China.
Objectives: This study explored the expression and diagnostic value of differentially expressed miR-3591-5p in congenital heart disease-associated pulmonary arterial hypertension (CHD-PAH).
Methods: A total of 110 CHD patients were divided into four groups based on their mean pulmonary artery pressure (PAPm). The plasma miR-3591-5p expression was determined by reverse transcription polymerase chain reaction.
Targeting Hypoxia and Autophagy Inhibition via Delivering Sonodynamic Nanoparticles With HIF-2α Inhibitor for Enhancing Immunotherapy in Renal Cell Carcinoma.
Adv Healthc Mater
December 2024
Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Article Synopsis
- * Sonodynamic therapy (SDT) can trigger the immune system but often faces challenges like hypoxia and cancer cell resistance due to autophagy.
- * A new polymer-based nanoparticle (APm/Ce6/HIF) that combines a HIF-2α inhibitor and ultrasonic sensitizer has been developed, which, when used with ultrasound, effectively reduces tumor growth and enhances the immune response, transforming the tumor environment for better ICB therapy effectiveness.
Tolerating Annotation Displacement in Dense Object Counting via Point Annotation Probability Map.
IEEE Trans Image Process
November 2023
Counting objects in crowded scenes remains a challenge to computer vision. The current deep learning based approach often formulate it as a Gaussian density regression problem. Such a brute-force regression, though effective, may not consider the annotation displacement properly which arises from the human annotation process and may lead to different distributions.
View Article and Find Full Text PDFExpression and clinical significance of miR-8078 in patients with congenital heart disease-associated pulmonary arterial hypertension.
Gene
February 2024
Department of Cardiology, Affiliated Hospital of Nantong University, Nantong 226000, China. Electronic address:
Objectives: This study aimed to analyze the plasma levels of miR-8078 in patients with congenital heart disease-associated pulmonary arterial hypertension (CHD-PAH) and to explore the diagnostic value and potential mechanisms of miR-8078 in CHD-PAH.
Methods: Plasma samples were collected from 110 patients with congenital heart disease. Subsequently, based on the mean pulmonary artery pressure (PAPm) measured via right heart catheterization, the patients were divided into three groups: no-PAH group (Group W, PAPm < 25 mmHg), mild group (Group M, 25 mmHg ≤ PAPm < 35 mmHg), and moderate-to-severe group (Group H, PAPm ≥ 35 mmHg).
A ROS-responsive synergistic delivery system for combined immunotherapy and chemotherapy.
Mater Today Bio
March 2022
Zhejiang Key Laboratory of Smart BioMaterials and Center for Bionanoengineering, College of Chemical and Biological Engineering, Zhejiang University, Hangzhou, 310027, China.
Immune checkpoint blockade (ICB) therapies that target programmed cell death-1 (PD-1)/programmed cell death-ligand 1 (PD-L1) pathway are currently used for the treatment of various cancer types. However, low response rates of ICB remain the major issue and limit their applications in clinic. Here, we developed a ROS-responsive synergistic delivery system (pep-PAPM@PTX) by integrating physically-encapsulated paclitaxel (PTX) and surface-modified anti-PD-L1 peptide (pep) for combined chemotherapy and ICB therapy.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!